Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of YIC therapeutic hepatitis B vaccine in HBeAg-positive chronic hepatitis B
ChiCTR-TRC-13003441Phase 3Completed
- Sponsor
- Beijing Ditan Hospital
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of YIC therapeutic hepatitis B vaccine in Chronic Hepatitis B (CHB) (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: HBeAg seroconversion. Started May 2013; status: completed.
02
Drugs
YIC therapeutic hepatitis B vaccine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-13003441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003441.